Dndi Drugs For Neglected Diseases Initiative India Foundation Profile
Key Indicators
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Dndi Drugs For Neglected Diseases Initiative India Foundation
Dndi Drugs For Neglected Diseases Initiative India Foundation (DDFNDIIF) is a Private Not For Profit Company incorporated in India on 27 May 2016 (Eight years and eight months 19 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Farhat Mantoo and Lalit Kant serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100DL2016NPL300545
-
Company No.
300545
-
Company Classification
Private Not For Profit Company
-
Incorporation Date
27 May 2016
-
Date of AGM
04 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dndi Drugs For Neglected Diseases Initiative India Foundation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalit Kant
|
Director | 27-May-2016 | Current |
|
Farhat Mantoo
|
Director | 07-Sep-2021 | Current |
Financial Performance of Dndi Drugs For Neglected Diseases Initiative India Foundation.
Dndi Drugs For Neglected Diseases Initiative India Foundation, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dndi Drugs For Neglected Diseases Initiative India Foundation?
Unlock access to Dndi Drugs For Neglected Diseases Initiative India Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dndi Drugs For Neglected Diseases Initiative India Foundation?
Unlock and access historical data on people associated with Dndi Drugs For Neglected Diseases Initiative India Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dndi Drugs For Neglected Diseases Initiative India Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dndi Drugs For Neglected Diseases Initiative India Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
